BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 33500211)

  • 1. Can hydroxychloroquine be protective against COVID-19-associated thrombotic events ?
    Devaux CA; Camoin-Jau L; Mege JL; Raoult D
    J Microbiol Immunol Infect; 2021 Feb; 54(1):37-45. PubMed ID: 33500211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine in the primary thrombosis prophylaxis of antiphospholipid antibody positive patients without systemic autoimmune disease.
    Erkan D; Unlu O; Sciascia S; Belmont HM; Branch DW; Cuadrado MJ; Gonzalez E; Knight JS; Uthman I; Willis R; Zhang Z; Wahl D; Zuily S; Tektonidou MG;
    Lupus; 2018 Mar; 27(3):399-406. PubMed ID: 28764618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxychloroquine as an anti-thrombotic in antiphospholipid syndrome.
    Belizna C
    Autoimmun Rev; 2015 Apr; 14(4):358-62. PubMed ID: 25534016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
    Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hydroxychloroquine to obtain pregnancy without adverse obstetrical events in primary antiphospholipid syndrome: French phase II multicenter randomized trial, HYDROSAPL].
    Mekinian A; Vicaut E; Cohen J; Bornes M; Kayem G; Fain O
    Gynecol Obstet Fertil Senol; 2018; 46(7-8):598-604. PubMed ID: 30041771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.
    Belizna C; Pregnolato F; Abad S; Alijotas-Reig J; Amital H; Amoura Z; Andreoli L; Andres E; Aouba A; Apras Bilgen S; Arnaud L; Bienvenu B; Bitsadze V; Blanco P; Blank M; Borghi MO; Caligaro A; Candrea E; Canti V; Chiche L; Chretien JM; Cohen Tervaert JW; Damian L; Delross T; Dernis E; Devreese K; Djokovic A; Esteve-Valverde E; Favaro M; Fassot C; Ferrer-Oliveras R; Godon A; Hamidou M; Hasan M; Henrion D; Imbert B; Jeandel PY; Jeannin P; Jego P; Jourde-Chiche N; Khizroeva J; Lambotte O; Landron C; Latino JO; Lazaro E; de Leeuw K; Le Gallou T; Kiliç L; Limper M; Loufrani L; Lubin R; Magy-Bertrand N; Mahe G; Makatsariya A; Martin T; Muchardt C; Nagy G; Omarjee L; Van Paasen P; Pernod G; Perrinet F; Pïres Rosa G; Pistorius MA; Ruffatti A; Said F; Saulnier P; Sene D; Sentilhes L; Shovman O; Sibilia J; Sinescu C; Stanisavljevic N; Stojanovich L; Tam LS; Tincani A; Tollis F; Udry S; Ungeheuer MN; Versini M; Cervera R; Meroni PL
    Autoimmun Rev; 2018 Dec; 17(12):1153-1168. PubMed ID: 30316994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study.
    Kravvariti E; Koutsogianni A; Samoli E; Sfikakis PP; Tektonidou MG
    Autoimmun Rev; 2020 Apr; 19(4):102491. PubMed ID: 32084592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Management of the antiphospholipid syndrome in adults].
    Doms J; Horisberger A; Ribi C
    Rev Med Suisse; 2020 Apr; 16(689):670-674. PubMed ID: 32270932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiphospholipid syndrome: still an enigma.
    Chaturvedi S; McCrae KR
    Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
    Meroni PL
    J Autoimmun; 2016 Dec; 75():1-5. PubMed ID: 27496152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy and Antiphospholipid Syndrome.
    Schreiber K; Hunt BJ
    Semin Thromb Hemost; 2016 Oct; 42(7):780-788. PubMed ID: 27652601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of hydroxychloroquine in altering pregnancy outcome in women with antiphospholipid antibodies. Evidence and clinical judgment.
    Sciascia S; Branch DW; Levy RA; Middeldorp S; Pavord S; Roccatello D; Ruiz-Irastorza G; Tincani A; Khamashta M; Schreiber K; Hunt BJ
    Thromb Haemost; 2016 Jan; 115(2):285-90. PubMed ID: 26421409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychloroquine as an Immunomodulatory and Antithrombotic Treatment in Antiphospholipid Syndrome.
    Arachchillage DJ; Laffan M; Pericleous C
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.
    Erkan D; Aguiar CL; Andrade D; Cohen H; Cuadrado MJ; Danowski A; Levy RA; Ortel TL; Rahman A; Salmon JE; Tektonidou MG; Willis R; Lockshin MD
    Autoimmun Rev; 2014 Jun; 13(6):685-96. PubMed ID: 24468415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical profiles and risk assessment in patients with antiphospholipid antibodies.
    Kato M; Hisada R; Atsumi T
    Expert Rev Clin Immunol; 2019 Jan; 15(1):73-81. PubMed ID: 30381978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of Recurrent Thrombosis in Antiphospholipid Syndrome: Different from the General Population?
    Legault KJ; Ugarte A; Crowther MA; Ruiz-Irastorza G
    Curr Rheumatol Rep; 2016 May; 18(5):26. PubMed ID: 27032789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic Management of Antiphospholipid Syndrome: Towards Novel Targeted Therapies.
    Islam MA; Alam F; Wong KK; Kamal MA; Gan SH
    Curr Vasc Pharmacol; 2017; 15(4):313-326. PubMed ID: 28056758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiphospholipid antibodies in patients with COVID-19: A relevant observation?
    Devreese KMJ; Linskens EA; Benoit D; Peperstraete H
    J Thromb Haemost; 2020 Sep; 18(9):2191-2201. PubMed ID: 32619328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis.
    Dong Y; Lu Y; Xia Y; Wang X
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):7084-7092. PubMed ID: 34182874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of antiphospholipid antibody syndrome: a systematic review.
    Lim W; Crowther MA; Eikelboom JW
    JAMA; 2006 Mar; 295(9):1050-7. PubMed ID: 16507806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.